Jessup Wealth Management Inc Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Jessup Wealth Management Inc raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 438.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,350 shares of the healthcare conglomerate's stock after purchasing an additional 5,170 shares during the period. UnitedHealth Group accounts for about 1.4% of Jessup Wealth Management Inc's portfolio, making the stock its 23rd biggest position. Jessup Wealth Management Inc's holdings in UnitedHealth Group were worth $3,326,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. Norges Bank purchased a new stake in UnitedHealth Group during the fourth quarter valued at approximately $6,375,744,000. GAMMA Investing LLC boosted its holdings in UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after acquiring an additional 8,280,404 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in UnitedHealth Group by 36.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after purchasing an additional 2,301,010 shares during the period. Northern Trust Corp boosted its stake in shares of UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock valued at $4,807,527,000 after purchasing an additional 1,058,488 shares during the period. Finally, Capital International Investors increased its stake in UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after buying an additional 906,365 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 1.6%

Shares of UNH stock traded down $4.80 during trading hours on Monday, reaching $303.75. 9,010,516 shares of the company's stock were exchanged, compared to its average volume of 7,565,853. The stock has a market cap of $275.54 billion, a PE ratio of 12.72, a PEG ratio of 1.48 and a beta of 0.45. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock's fifty day moving average price is $324.99 and its two-hundred day moving average price is $447.02.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the previous year, the company posted $6.91 EPS. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.91%. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

Analyst Ratings Changes

A number of brokerages have recently commented on UNH. Royal Bank Of Canada reduced their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. TD Securities reaffirmed a "hold" rating and set a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a research report on Monday, May 19th. Bank of America lowered UnitedHealth Group from a "buy" rating to a "neutral" rating and decreased their target price for the company from $560.00 to $350.00 in a research report on Wednesday, May 14th. Finally, Erste Group Bank lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $415.57.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Kristen Gil acquired 3,700 shares of UnitedHealth Group stock in a transaction on Thursday, May 15th. The stock was acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director owned 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Stephen J. Hemsley acquired 86,700 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The shares were bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the purchase, the chief executive officer directly owned 679,493 shares in the company, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have bought 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.